Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system

Neurochemistry International

Volumn 57, Issue 5, 2010, Pages 579-587

  Sandhir, Rajat ^a   Mehrotra, Arpit ^a   Kamboj, Sukhdev S ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

3 Nitropropionic acid; Antioxidants; Brain; Huntington's disease; Lycopene; Mitochondria; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; CASPASE 3; CYTOCHROME C; CYTOCHROME C OXIDASE; LYCOPENE; NITRITE; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; FEMALE; HUNTINGTON CHOREA; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS REGULATORY PROTEINS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CAROTENOIDS; COLORING AGENTS; FEMALE; LIPID PEROXIDATION; MAZE LEARNING; MITOCHONDRIA; NERVOUS SYSTEM; NITRITES; NITRO COMPOUNDS; OXIDATIVE STRESS; PERMEABILITY; POSTURAL BALANCE; PROPIONIC ACIDS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; THIAZOLES;

ANIMALIA; RATTUS;

EID: 77956227700     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.07.005     Document Type: Article

References (94)

1. Abe K., Saito H. Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci. Res. 1998, 31:295-305.
2. Akbaraly N.T., Faure H., Gourlet V., Favier A., Berr C. Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA study. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:308-316.
3. Alexi T., Hughes P.E., Faull R.L., Williams C.E. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 1998, 9:57-64.
4. Antonawich F.J., Fiore-Marasa S.M., Parker C.P. Modulation of apoptotic regulatory proteins and early activation of cytochrome c following systemic 3-nitropropionic acid administration. Brain Res. Bull. 2002, 57:647-649.
5. Bae B.I., Xu H., Igarashi S., Fujimuro M., Agrawal N., Taya Y., Hayward S.D., Moran T.H., Montell C., Ross C.A., Snyder S.H., Sawa A. p53 Mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 2005, 47:29-41.
6. Barquero-Jiménez M.S., Gómez-Tortosa E. Cognitive disorders in patients with Huntington's disease. Rev. Neurol. 2001, 32:1067-1071.
7. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta. 1998, 1366:211-223.
8. Benchoua A., Trioulier Y., Zala D., Gaillard M.C., Lefort N., Dufour N., Saudou F., Elalouf J.M., Hirsch E., Hantraye P., Déglon N., Brouillet E. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin. Mol. Biol. Cell 2006, 17:1652-1663.
9. Ben-Dor A., Steiner M., Gheber L., Danilenko M., Dubi N., Linnewiel K., Zick A., Sharoni Y., Levy J. Carotenoids activate the antioxidant response element transcription system. Mol. Cancer Ther. 2005, 4:177-186.
10. Bhuvaneshwari V., Velmurugan B., Balasenthil S., Ramacahandran C.R., Nagini S. Chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Fitoterapia 2001, 72:865-874.
11. Binienda Z., Simmons C., Hussain S., Slikker J., Ali S.F. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain. Neurosci. Lett. 1998, 251:173-176.
12. Bizat N., Hermel J.M., Boyer F., Jacquard C., Creminon C., Ouary S., Escartin C., Hantraye P., Kajewski S., Brouillet E. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J. Neurosci. 2003, 23:5020-5030.
13. Brouillet E., Jacquard C., Bizat N., Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 2005, 95:1521-1540.
14. Browne S.E., Bowling A.C., Macgarvey U. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 1997, 41:646-653.
15. Chen C.M., Cheng M.L., Liu J.L., Lee Y.M., Lee P.W., Soong B.W., Chiu D.T. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Biochem. Biophys. Res. Commun. 2007, 359:335-340.
16. Cirillo G., Maggio N., Bianco M.R., Vollono C., Sellitti S., Papa M. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats. Neurochem. Int. 2010, 56:152-160.
17. Conn P.F., Schalch W., Truscott T.G. The singlet oxygen and carotenoid interaction. J. Photochem. Photobiol. B. 1991, 11:41-47.
18. De-Stefano D., Maiuri M.C., Simeon V., Grassia G., Soscia A., Cinelli M.P., Carnuccio R. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur. J. Pharmacol. 2007, 566:192-199.
19. Fekete Á., Vizi E.S., Kovács K.J., Lendvai B., Zelles T. Layer-specific differences in reactive oxygen species levels after oxygen-glucose deprivation in acute hippocampal slices. Free Radc. Biol. Med. 2008, 44:1010-1022.
20. Feng D., Ling W.H., Duan R.D. Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kB in macrophages. Inflamm. Res. 2010, 59:115-121.
21. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925, 66:375-400.
22. Fontaine M.A.L., Geddes J.W., Banks A., Butterfield D.A. Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions. J. Neurochem. 2000, 75:1709-1715.
23. Forsmark-Andree P., Lee C.P., Dallner G., Ernster L. Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles. Free Radic. Biol. Med. 1997, 22:391-400.
24. Garcia O., Almeida A., Massieu L., Bolanos J.P. Increased mitochondrial respiration maintains the mitochondrial membrane potential and promotes survival of cerebellar neurons in an endogenous model of glutamate receptor activation. J. Neurochem. 2005, 92:183-190.
25. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van L.H., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni R.J., Roy S., Nicholson D.W. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999, 97:395-406.
26. 15N] nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
27. Griffiths D.E., Houghton R.L. Studies on energy linked reactions: modified mitochondrial ATPase of oligomycin-resistant mutants of Saccharomyces cerevisiae. Eur. J. Biochem. 1974, 46:157-167.
28. 1 ATP-synthase of cardiac muscle during aging. Cardioscience 1993, 4:93-98.
29. Gunasekera R.S., Sewgobind K., Desai S., Dunn L., Black H.S., McKeehan W.L., Patil B. Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells. Nutr. Cancer 2007, 58:171-177.
30. Henderson J.M., Schleimer S.B., Allbutt H., Dabholkar V., Abela D., Jovic J., Quinlivan M. Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism. Behav. Brain Res. 2005, 162:222-232.
31. Hsiao G., Fong T.H., Tzu N.H., Lin K.H., Chou D.S., Sheu J.R. A potent antioxidant lycopene, affords neuroprotection against microglia activation and focal cerebral ischemia in rats. In Vivo 2004, 18:351-356.
32. Indo H.P., Davidson M., Yen H.C., Suenaga S., Tomita K., Nishii T. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007, 7:106-118.
33. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur. J. Pharmacol. 1991, 194:71-76.
34. 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology 1998, 50:1357-1365.
35. Jin Y.N., Johnson G.V. The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. J. Bioenerg. Biomembr. 2010, 42:199-205.
36. Kamboj S.S., Kumar V., Kamboj A., Sandhir R. Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure. Cell. Mol. Neurobiol. 2008, 28:961-969.
37. King T.E., Howard R.L. Preparation and properties of soluble NADH dehydrogenase from cardiac muscle. Methods Enzymol. 1967, 10:322-331.
38. King T.E., Ohnishi T., Winter D.B., Wu J.T. Biochemical and EPR probes for structure-function studies of iron sulfur centers of succinate dehydrogenase. Adv. Exp. Med. Biol. 1976, 74:182-227.
39. Kong K.W., Khoo H.E., Prasad K.N., Ismail A., Tan C.P., Rajab N.F. Revealing the power of natural red pigment lycopene. Molecules 2010, 15:959-987.
40. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186:189-195.
41. Kroemer G., Reed J.C. Mitochondrial control of death. Nat. Med. 2000, 6:513-519.
42. Kuhad A., Sethi R., Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci. 2008, 83:128-134.
43. Kuhl D.E., Phelps M.E., Markham C.H. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann. Neurol. 1982, 12:425-434.
44. Kumar P., Kalonia H., Kumar A. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Life Sci. 2009, 85:711-718.
45. Kumar P., Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem. Toxicol. 2009, 47:2522-2530.
46. Leal M., Shimada A., Ruiz F., Gonzalez M.E. Effect of lycopene on lipid peroxidation and glutathione-dependent enzymes induced by T-2 toxin in vivo. Toxicol. Lett. 1999, 109:1-10.
47. Lee W.T., Chang C. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease. Prog. Neurobiol. 2004, 72:87-110.
48. Lee W.T., Shen Y.Z., Chang C. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience 2000, 95:89-95.
49. Liot G., Bossy B., Lubitz S., Kushnareva Y., Sejbuk N., Bossy-Wetzel E. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ. 2009, 16:899-909.
50. Liu C., Russell R.M., Wang X.D. Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J. Nutr. 2006, 136:106-111.
51. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
52. Ludolph A.C., He F., Spencer P.S., Hammerstad J., Sabri M. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 1991, 18:492-498.
53. McCarty M.F. Up-regulation of endothelial nitric oxide activity as a central strategy for prevention of ischemic stroke-Just say NO to stroke!. Med. Hypotheses 2000, 55:386-403.
54. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 1995, 1271:35-42.
55. Miller N.J., Sampson J., Candeias L.P., Bramley P.M., Rice-Evans C.A. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996, 384:240-242.
56. Montilla P., Tunez I., Munoz M.C., Salcedo M., Feijoo M., Munoz-Castaneda J.R., Bujalance I. Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. Eur. J. Pharmacol. 2004, 488:19-25.
57. Montoya A., Price B.H., Menear M., Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J. Psychiatry Neurosci. 2006, 31:21-29.
58. Muzandu K., Ishizuka M., Sakamoto K.Q., Shaban Z., El B.K., Kazusaka A., Fujita S. Effect of lycopene and β-carotene on peroxynitrite-mediated cellular modifications. Toxicol. Appl. Pharmacol. 2006, 215:330-340.
59. Nasr P., Carbery T., Geddes J.W. N-methyl-d-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity. Neurochem. Res. 2009, 34:490-498.
60. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
61. Oliveira J.M.A. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J. Neurochem. 2010, 114:1-12.
62. Pandey M., Borah A., Varghese M., Barman P.K., Mohanakumar K.P., Usha R. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats. Neurochem. Int. 2009, 55:431-437.
63. Pérez-Pinzón M.A., Xu G.P., Born J., Lorenzo J., Busto R., Rosenthal M., Sick T.J. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J. Cereb. Blood Flow Metab. 1999, 19:39-43.
64. Puka-Sundvall M., Wallin C., Gilland E., Hallin U., Wang X., Sandberg M., Karlsson J., Blomgren K., Hagberg H. Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury. Brain Res. Dev. Brain Res. 2000, 125:43-50.
65. Rao A.V., Rao L.G. Carotenoids and human health. Pharmacol. Res. 2007, 55:207-216.
66. Rao A.V., Ray M.R., Rao L.G. Lycopene. Adv. Food Nutr. Res. 2006, 51:99-164.
67. Riso P., Brusamolino A., Martinetti A., Porrini M. Effect of a tomato drink intervention on insulin-like growth factor (IGF-1) serum levels in healthy subjects. Nutr. Cancer 2006, 55:157-162.
68. Roberts J.C., Francetic D.J. The importance of sample preparation and storage in glutathione analysis. Anal. Biochem. 1993, 211:183-187.
69. Ross C.A. Huntington's disease: new paths to pathogenesis. Cell 2004, 118:4-7.
70. Schulz J.B., Henshaw D.R., MacGarvey U., Beal M.F. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem. Int. 1996, 29:167-171.
71. Seaman R.L. Effects of acute systemic 3-nitropropionic acid administration on rat activity and acoustic startle. Neurosci. Lett. 2000, 280:183-186.
72. Sedlák J., Hanus L. Changes of glutathione and protein bound SH-groups concentration in rat adrenals under acute and repeated stress. Endocrinol. Exp. 1982, 16:103-109.
73. Singh R.P., Sharad S., Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. J. Ind. Acad. Clin. Med. 2004, 5:218-225.
74. Sokol J.R., Dwereaux M., Khandwala R.A. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J. Lipid Res. 1991, 32:1349-1357.
75. Sottocasa G.L., Kuylenstierna B., Ernster L., Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J. Cell Biol. 1967, 32:415-438.
76. Srinivasan M., Devipriya N., Kalpana K.B., Menon V.P. Lycopene: an antioxidant and radioprotector against gamma-radiation-induced cellular damages in cultured human lymphocytes. Toxicology 2009, 262:43-49.
77. Su B., Wang X., Zheng L., Perry G., Smith M.A., Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim. Biophys. Acta Mol. Basis Dis. 2010, 1802:135-142.
78. Tabrizi S.J., Cleeter M.W., Xuereb J., Taanman J.W., Cooper J.M., Schapira A.H. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol. 1999, 45:25-32.
79. Tabrizi S.J., Workman J., Hart P.E., Mangiarini L., Mahal A., Bates G., Cooper J.M., Schapira A.H. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol. 2000, 47:80-86.
80. 2-induced oxidative injury and apoptosis in human endothelial cells. Cardiovasc. Drugs Ther. 2009, 23:439-448.
81. Tariq M., Khan H.A., Elfaki I., Deeb S.A., Moutaery K.A. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res. Bull. 2005, 67:161-168.
82. Tedeshi H., Harris D.L. Some observations on the photometric estimation of mitochondrial volume. Biochim. Biophys. Acta 1958, 28:392-402.
83. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992, 24:145-149.
84. Türk G., Ceribaşi A.O., Sakin F., Sönmez M., Ateşşahin A. Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis. Reprod. Fertil. Dev. 2010, 22:587-596.
85. Upaganlawar A., Gandhi H., Balaraman R. Effect of vitamin E alone and in combination with lycopene on biochemical and histopathological alterations in isoproterenol-induced myocardial infarction in rats. J. Pharmacol. Pharmacother. 2010, 1:24-31.
86. Vatassery G.T., Lai J.C., DeMaster E.G., Smith W.E., Quach H.T. Oxidation of vitamin E and vitamin C and inhabitation of brain mitochondrial oxidative phosphorylation by peroxynitrite. J. Nuerosci. Res. 2004, 75:845-853.
87. Villarán R.F., Tomás-camardiel M., De-pablos R.M., Santiago M., Herrera A.J., Navarro A., Machado A., Cano J. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 2008, 29:244-258.
88. Virmani A., Gaetani F., Binienda Z. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. Ann. N. Y. Acad. Sci. 2005, 1053:183-191.
89. Vonsattel J.P., Meyers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
90. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
91. Wenli Y., Yaping Z. Chemiluminescence evaluation of oxidative damage to biomolecules induced by singlet oxygen and the protective effects of antioxidants. Biochim. Biophys. Acta 2005, 1725:30-34.
92. Woodall A.A., Britton G., Jackson M.J. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. Biochim. Biophys. Acta 1997, 1336:575-586.
93. Yang L., Calingasan N.Y., Chen J., Ley J.J., Becker D.A., Beal M.F. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities. Exp. Neurol. 2005, 191:86-93.
94. Zhang X.D., Wang Y., Wang Y., Zhang X., Han R., Wu J.C., Liang Z.Q., Gu Z.L., Han F., Fukunaga K., Qin Z.H. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 2009, 5:339-350.